Literature DB >> 12706306

A complex heterozygous mutation of His373Leu and Asp487-Ser488-Phe489 deletion in human cytochrome P450c17 causes 17alpha-hydroxylase/17,20-lyase deficiency in three Chinese sisters.

Jie Qiao1, Ren-Ming Hu, Yong-De Peng, Huai-Dong Song, Yi-Wen Peng, Guo-Feng Gao, Jian-Hua Hao, Nan-Ying Hu, Man-Yin Xu, Jia-Lun Chen.   

Abstract

Cytochrome P450c17 deficiency is one of the rare forms of enzyme disorders in steroid biosynthesis, resulting from defects in 17alpha-hydroxylase and 17,20-lyase activities. The disease is caused by the mutations in CYP17 gene, inherited in an autosomal recessive pattern. We reported a Chinese family with three sisters suffering from P450c17 deficiency based on their clinical features and molecular genetics. The patients were found to be compound heterozygotes with two different mutations. Screened by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP), a heterozygous point mutation His373Leu was detected in the exon 6 of CYP17 gene which was proved to be derived from paternal allele. The other allele contained nine-base pair deletion, located in exon 8, eliminating codons 487-489 (Asp-Ser-Phe) near the carboxy-terminus of P450c17. The mother and the brother have been demonstrated to be carriers of deletion mutation through restriction enzyme analysis. Both mutations have been reported previously in Asia. This is the first report of the molecular genetic study of 17alpha-hydroxylase/17,20-lyase deficiency in mainland China with a novel compound heterozygous mutation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12706306     DOI: 10.1016/s0303-7207(02)00156-9

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  6 in total

1.  Clinical and molecular manifestation of fifteen 17OHD patients: a novel mutation and a founder effect.

Authors:  Bing Han; Liqiong Xue; Mengxia Fan; Shuangxia Zhao; Wei Liu; Hui Zhu; Tong Cheng; Yingli Lu; Kaixiang Cheng; Huaidong Song; Yang Liu; Jie Qiao
Journal:  Endocrine       Date:  2016-05-05       Impact factor: 3.633

2.  CYP17A1 intron mutation causing cryptic splicing in 17α-hydroxylase deficiency.

Authors:  Daw-Yang Hwang; Chi-Chih Hung; Felix G Riepe; Richard J Auchus; Alexandra E Kulle; Paul-Martin Holterhus; Mei-Chyn Chao; Mei-Chuan Kuo; Shang-Jyh Hwang; Hung-Chun Chen
Journal:  PLoS One       Date:  2011-09-26       Impact factor: 3.240

Review 3.  Reproductive endocrine characteristics and in vitro fertilization treatment of female patients with partial 17α-hydroxylase deficiency: Two pedigree investigations and a literature review.

Authors:  Shutian Jiang; Yue Xu; Jie Qiao; Yao Wang; Yanping Kuang
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-14       Impact factor: 6.055

4.  Untreated Congenital Adrenal Hyperplasia with 17-α Hydroxylase/17,20-Lyase Deficiency Presenting as Massive Adrenocortical Tumor.

Authors:  Su Jin Lee; Je Eun Song; Sena Hwang; Ji Yeon Lee; Hye Sun Park; Seunghee Han; Yumie Rhee
Journal:  Endocrinol Metab (Seoul)       Date:  2015-08-04

5.  A novel CYP17A1 deletion causes a functional knockout of the steroid enzyme 17-hydroxylase and 17,20-lyase in a Turkish family and illustrates the precise role of the CYP17A1 gene.

Authors:  Núria Camats; Ala Üstyol; Mehmet Emre Atabek; Bernhard Dick; Christa E Flück
Journal:  Clin Case Rep       Date:  2015-08-26

6.  Functional Identification of Compound Heterozygous Mutations in the CYP17A1 Gene Resulting in Combined 17α-Hydroxylase/17,20-Lyase Deficiency.

Authors:  Eun Yeong Mo; Ji Young Lee; Su Yeon Kim; Min Ji Kim; Eun Sook Kim; Seungok Lee; Je Ho Han; Sung Dae Moon
Journal:  Endocrinol Metab (Seoul)       Date:  2018-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.